Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Tan

Showing results (251-260 of 317) with videos related to

Pageof 32
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2019
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLCWan Ling Tan, Kevin L M Chua, Chia-Chi Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 TrialVivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|March 6, 2025
Psychometric evaluation and computerized adaptive testing simulations of age-related macular degeneration quality of life item banksEva K Fenwick, Ryan E K Man, Anna C S Tan, et al.
Cell Reports. Medicine|November 18, 2020
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal CancerShamin Li, Yannick Simoni, Etienne Becht, et al.
NPJ Digital Medicine|March 29, 2020
Technical and imaging factors influencing performance of deep learning systems for diabetic retinopathyMichelle Y T Yip, Gilbert Lim, Zhan Wei Lim, et al.
Nature Cancer|May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trialSolange Peters, Daniel S W Tan, David E Gerber, et al.
Nature Communications|December 24, 2015
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparumJigang Wang, Chong-Jing Zhang, Wan Ni Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerJ J Lin, S V Liu, C E McCoach, et al.
The New England Journal of Medicine|March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancerAlice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.
Scientific Reports|December 9, 2023
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Yue Gu, Bhuvaneshwari Shunmuganathan, Xinlei Qian, et al.
Pageof 32

Showing results (251-260 of 317) with videos related to

Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2019
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLCWan Ling Tan, Kevin L M Chua, Chia-Chi Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 TrialVivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|March 6, 2025
Psychometric evaluation and computerized adaptive testing simulations of age-related macular degeneration quality of life item banksEva K Fenwick, Ryan E K Man, Anna C S Tan, et al.
Cell Reports. Medicine|November 18, 2020
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal CancerShamin Li, Yannick Simoni, Etienne Becht, et al.
NPJ Digital Medicine|March 29, 2020
Technical and imaging factors influencing performance of deep learning systems for diabetic retinopathyMichelle Y T Yip, Gilbert Lim, Zhan Wei Lim, et al.
Nature Cancer|May 13, 2026
Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trialSolange Peters, Daniel S W Tan, David E Gerber, et al.
Nature Communications|December 24, 2015
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparumJigang Wang, Chong-Jing Zhang, Wan Ni Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerJ J Lin, S V Liu, C E McCoach, et al.
The New England Journal of Medicine|March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancerAlice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.
Scientific Reports|December 9, 2023
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Yue Gu, Bhuvaneshwari Shunmuganathan, Xinlei Qian, et al.
Pageof 32